Versuchen GOLD - Frei
Female Workforce In Pharma: Knocking On The Glass Ceiling?
Express Pharma
|March 01-15, 2020
With roughly only one women out of ten professionals constituting the workforce of the Indian pharma industry, it seems that it may take a long while before the sector can claim a healthy gender diversity ratio. However, despite the challenges, women stalwarts are defying stereotypes to create space for more ladies in top leadership in the India Pharma Inc
Nationwide, most industries are guilty of having skewed gender equality ratios and the Indian pharmaceutical industry is no exception. According to a report published by Mercer India, female representation in the pharma industry is just 11 per cent — of the 49.5-million-plus strong. The statistics vary across sectors. While female representation in the manufacturing function stands at 12 per cent, 17 per cent in R&D and 21 per cent in corporate functions, it slopes down to a mere 5 per cent in the sales and marketing function.
The figures are even more dismal when it comes to the percentage of women in top leadership roles. Yes, the industry can boast of a few women leaders — like Biocon’s Kiran Mazumdar-Shaw. But the truth is that a lot more numbers need to be added up before the Indian pharma industry can fix the gender gap in its top leadership.
Unfortunately, it is nothing less than ironical that while traditionally, women are the main healthcare providers at homes, their representation in an industry that is the backbone of the country’s healthcare system is completely disproportionate, especially in top leadership roles. However, interestingly, it could very well be that pharma companies could actually gain by improving their workforce’s gender diversity.
According to a 2018 report by McKinsey Global Institute, India could add up to $0.7 trillion — more than 18 per cent — to its GDP by 2025, simply by paying attention to the slanting balance of its gender equality scales. Also, it is only fair that companies should represent and reflect their customers and their end-users.
But, what are the challenges that limit women from scaling the ladder to the top in the pharma sector?
Stuck with stereotypes?
Diese Geschichte stammt aus der March 01-15, 2020-Ausgabe von Express Pharma.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Express Pharma
Express Pharma
Speed and flexibility play a critical role in how we compete with larger global players
Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma
6 mins
January 2026
Express Pharma
Vizag rising: Shaping India's pharma future
At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth
9 mins
January 2026
Express Pharma
Future of pharma: Trends, challenges & AI
Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies
2 mins
January 2026
Express Pharma
Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments
When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.
1 mins
January 2026
Express Pharma
Can Indian biosimilars and generics restate accessibility in global underserved markets?
Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare
3 mins
January 2026
Express Pharma
The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers
As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.
6 mins
January 2026
Express Pharma
Results win customers. Leadership discipline keeps them
Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.
3 mins
January 2026
Express Pharma
INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF
India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge
8 mins
January 2026
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 mins
January 2026
Express Pharma
Odisha's pharma pitch
The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury
5 mins
January 2026
Translate
Change font size
